Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, June 11, 2018

Sickle cell trait may not increase stroke risk in black adults

Are you refuting this from Dec. 2009? Talk to your doctor. Notice mean age in study - 60 years.

Twenty-four percent of sickle cell disease (SCD) patients have a stroke by the age of 45 years Dec. 2009 

Sickle cell trait may not increase stroke risk in black adults


Black adults with sickle cell trait did not have an increased risk for ischemic stroke, according to a meta-analysis published in JAMA Neurology.
Hyacinth I. Hyacinth, MD, PhD, MPH, associate professor in the department of pediatrics at Emory University School of Medicine, and colleagues analyzed data from 19,464 black adults (mean age, 60 years; 27% men) from four studies: Jackson Heart Study, REGARDS, MESA and Women’s Health Initiative. Of these participants, 1,520 had sickle cell trait and 620 had incident ischemic stroke.
Baseline information was collected by self-report and in-person examination, and patients were followed up annually or semiannually for the occurrence of CV events, including stroke. Exclusion criteria for this meta-analysis included those with a history of stroke at baseline and incident hemorrhagic stroke.
Risk factors, age at ischemic stroke event and the number of strokes did not differ in patients with and without sickle cell trait.
The crude incidence of ischemic stroke was similar in people with sickle cell trait (2.9 per 1,000 person-years; 95% CI, 2.2-4) and without it (3.2 per 1,000 person-years; 95% CI, 2.7-3.8). After adjusting for stroke risk factors, HRs did not significantly differ between both groups (HR = 0.8; 95% CI, 0.47-1.35).
Results were similar in both the individual cohorts and the meta-analysis.
“Future studies with large numbers of African-Americans, longer follow-up and carefully subtyped ischemic stroke events are needed to further elucidate the possible association of [sickle cell trait] with incident ischemic stroke overall and by specific ischemic stroke subtypes,” Hyacinth and colleagues wrote. – by Darlene Dobkowski
Disclosure s : The authors report no relevant financial disclosures.

No comments:

Post a Comment